These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11564802)

  • 1. Conventional and surrogate light chains differentially regulate Ig mu and Dmu heavy chain maturation and surface expression.
    Fang T; Smith BP; Roman CA
    J Immunol; 2001 Oct; 167(7):3846-57. PubMed ID: 11564802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
    Guloglu FB; Bajor E; Smith BP; Roman CA
    J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate.
    Bradl H; Wittmann J; Milius D; Vettermann C; Jäck HM
    J Immunol; 2003 Sep; 171(5):2338-48. PubMed ID: 12928380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple levels of selection responsive to immunoglobulin light chain and heavy chain structures impede the development of Dmu-expressing B cells.
    Guloglu FB; Smith BP; Roman CA
    J Immunol; 2008 Sep; 181(6):4098-106. PubMed ID: 18768866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VpreB protein of the surrogate light-chain can pair with some mu heavy-chains in the absence of the lambda 5 protein.
    Seidl T; Rolink A; Melchers F
    Eur J Immunol; 2001 Jul; 31(7):1999-2006. PubMed ID: 11449352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: signaling and cell surface expression of a mu H chain in the absence of lambda 5: a paradigm revisited.
    Schuh W; Meister S; Roth E; Jäck HM
    J Immunol; 2003 Oct; 171(7):3343-7. PubMed ID: 14500626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components.
    Galler GR; Mundt C; Parker M; Pelanda R; Mårtensson IL; Winkler TH
    J Exp Med; 2004 Jun; 199(11):1523-32. PubMed ID: 15173209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unique and immunoglobulin-like regions of surrogate light chain component lambda5 differentially interrogate immunoglobulin heavy-chain structure.
    Smith BP; Roman CA
    Mol Immunol; 2010 Mar; 47(6):1195-206. PubMed ID: 20116104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated immunoglobulin Dmu causes incomplete developmental progression of RAG-deficient pro-B cells.
    Malynn BA; Shaw AC; Young F; Stewart V; Alt FW
    Mol Immunol; 2002 Jan; 38(7):547-56. PubMed ID: 11750656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
    Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
    Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Ig mu heavy chains by complementarity-determining region 3 length and amino acid composition.
    Martin DA; Bradl H; Collins TJ; Roth E; Jäck HM; Wu GE
    J Immunol; 2003 Nov; 171(9):4663-71. PubMed ID: 14568941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of soluble pre-B cell receptors by pre-B cells.
    Bornemann KD; Brewer JW; Perez E; Doerre S; Sita R; Corley RB
    J Immunol; 1997 Mar; 158(6):2551-7. PubMed ID: 9058786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice.
    Mårtensson A; Argon Y; Melchers F; Dul JL; Mårtensson IL
    Int Immunol; 1999 Mar; 11(3):453-60. PubMed ID: 10221657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain.
    Minegishi Y; Hendershot LM; Conley ME
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3041-6. PubMed ID: 10077633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin mu heavy chains do not mediate tyrosine phosphorylation of Ig alpha from the ER-cis-Golgi.
    Mielenz D; Ruschel A; Vettermann C; Jäck HM
    J Immunol; 2003 Sep; 171(6):3091-101. PubMed ID: 12960335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.